Product Information

SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $9.5833 per EA under NDC 43598061930. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Aug 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET

Saxagliptin and Metformin Hydrochloride
$9.5833per EA

Strength

1000; 5 mg/1; mg/1

NDC

43598061930

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207678

FDA Approved

8/9/2023

TE Code

AB

On Market Since

8/9/2023

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET has been published 136 times since Apr 17, 2024, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.

Current price$9.5833 per EA
All-time high$10.6076 (Apr 15, 2026)
All-time low$8.4798 (May 22, 2024)
52-week high$10.6076
52-week low$9.3906
Median price$9.7944
Average price$9.7839
Largest weekly change+11.4% (Jun 19, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+2.1%

1M

-0.7%

3M

-3.3%

6M

-8.5%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

+6.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Saxagliptin and Metformin Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $9.5833 per EA (NDC 43598061930), effective Nov 18, 2026.

How has the price of SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET has risen 6.9%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?

Since Apr 17, 2024, the NADAC for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET has ranged from a low of $8.4798 (May 22, 2024) to a high of $10.6076 (Apr 15, 2026), with a median of $9.7944 per EA.

Are there cheaper alternatives to SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?

SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET (NDC 43598061930) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.